Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Long-term discontinuation of warfarin in a patient with HeartMate 3 left ventricular assist device without complication. J Card Surg 2020 Feb;35(2):447-449

Date

11/16/2019

Pubmed ID

31730719

DOI

10.1111/jocs.14352

Scopus ID

2-s2.0-85075524555 (requires institutional sign-in at Scopus site)   9 Citations

Abstract

A 38-year-old woman with peripartum cardiomyopathy underwent placement of a HeartMate 3 (HM3) left ventricular assist device (LVAD). Postoperatively, she refused warfarin therapy and was maintained on aspirin monotherapy for 19 months. She did not experience thrombotic or thromboembolic complications associated with lack of oral vitamin K antagonist anticoagulation. Our patient represents the longest reported duration of a patient with HM3 LVAD maintained without warfarin without evidence of thrombotic or thromboembolic events.

Author List

Fiedler AG, Hermsen JL, Smith JW, Dhingra R

Author

Ravi Dhingra MBBS Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Anticoagulants
Aspirin
Cardiomyopathies
Female
Heart Ventricles
Heart-Assist Devices
Humans
Thromboembolism
Time Factors
Treatment Refusal
Warfarin
Withholding Treatment